Cancer

Christopher Kane, MD, a distinguished figure in urology and the current CEO of the UC San Diego Health Physician Group,...

Liver cancer remains one of the most formidable challenges in oncology, with hepatocarcinoma—or hepatocellular carcinoma (HCC)—standing as its most commonly...

In recent years, the “obesity paradox” has challenged long-standing assumptions about body weight and health outcomes, particularly in cardiovascular disease....

In a groundbreaking advancement in breast cancer screening, researchers have identified that abbreviated breast magnetic resonance imaging (MRI) protocols can...

In the challenging landscape of pancreatic ductal adenocarcinoma (PDAC) treatment, surgical resection remains a cornerstone despite the high risk of...

In a remarkable advance in cancer immunotherapy, a novel targeted immune treatment has brought lasting remission to a patient suffering...

In a landmark advancement poised to reshape prognostic evaluation in epithelial ovarian cancer (EOC), researchers have successfully developed and validated...

In the ever-evolving landscape of lung cancer research, a recent real-world study published in BMC Cancer shines new light on...

In Puerto Rico, colorectal cancer (CRC) stands as the leading cause of cancer-related mortality, presenting a formidable challenge to healthcare...

A groundbreaking international study has revealed that pioglitazone, a drug primarily used in the treatment of type 2 diabetes, may...